Antonio Lanzavecchia
Corporate Officer/Principal chez VIR BIOTECHNOLOGY, INC.
Profil
Antonio Lanzavecchia is the founder of Humabs BioMed SA. He currently holds multiple positions including Director at Adienne SA, Professor at Università della Svizzera Italiana, Swiss Federal Institute of Technology, and the University of Genoa, Member of the National Academy of Sciences, European Molecular Biology Organization, and Swiss Academy of Medical Sciences, and Senior Vice President at Vir Biotechnology, Inc. Previously, he was a Member at Basel Institute for Immunology from 1983 to 1999.
He received his undergraduate degree from the University of Pavia.
Postes actifs de Antonio Lanzavecchia
| Sociétés | Poste | Début |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - |
Adienne SA
 Adienne SA Pharmaceuticals: OtherHealth Technology Adienne SA is a biopharmaceutical company engages in the provision of medical development. It focuses on orphan drugs for the treatment of various haematological and immunological diseases. The company was founded on Lugano, Switzerland. | Director/Board Member | - |
Institute For Research In Biomedicine
 Institute For Research In Biomedicine BiotechnologyHealth Technology The Institute for Research in Biomedicine provides research and development services in the field of biomedicine. | Director/Board Member | 01/01/2000 |
Humabs BioMed SA
 Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Founder | 01/08/2011 |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
| Università della Svizzera Italiana | Corporate Officer/Principal | - |
| University of Genoa | Corporate Officer/Principal | - |
| Swiss Federal Institute of Technology | Corporate Officer/Principal | - |
| European Molecular Biology Organization | Corporate Officer/Principal | - |
| ░░░░░ ░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Antonio Lanzavecchia
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Antonio Lanzavecchia
| University of Pavia | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
| European Molecular Biology Organization | |
| Swiss Academy of Medical Sciences | |
Humabs BioMed SA
Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Commercial Services |
Adienne SA
Adienne SA Pharmaceuticals: OtherHealth Technology Adienne SA is a biopharmaceutical company engages in the provision of medical development. It focuses on orphan drugs for the treatment of various haematological and immunological diseases. The company was founded on Lugano, Switzerland. | Health Technology |
Institute For Research In Biomedicine
Institute For Research In Biomedicine BiotechnologyHealth Technology The Institute for Research in Biomedicine provides research and development services in the field of biomedicine. | Health Technology |
